Literature DB >> 21507814

Patient factors that influence warfarin dose response.

Pamela J White1.   

Abstract

Warfarin has long been the mainstay of oral anticoagulation therapy for the treatment and prevention of venous and arterial thrombosis. The narrow therapeutic index of warfarin, and the complex number of factors that influence international normalized ratio (INR) response, makes optimization of warfarin therapy challenging. Determination of the appropriate warfarin dose during initiation and maintenance therapy requires an understanding of patient factors that influence dose response: age, body weight, nutritional status, acute and chronic disease states, and changes in concomitant drug therapy and diet. This review will examine specific clinical factors that can affect the pharmacokinetics and pharmacodynamics of warfarin, as well as the role of pharmacogenetics in optimizing warfarin therapy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21507814     DOI: 10.1177/0897190010362177

Source DB:  PubMed          Journal:  J Pharm Pract        ISSN: 0897-1900


  10 in total

1.  Clinical validation of a new algorithm for computerized dosing of vitamin K antagonist therapy: a retrospective simulation study.

Authors:  Michela Basileo; Carlo Micheluzzi; Marina Minozzi; Luigi Lazzaroni; Alfonso Iorio
Journal:  Intern Emerg Med       Date:  2011-04-06       Impact factor: 3.397

2.  Sensitivity to warfarin following cardiac surgery.

Authors:  Keyhan Mohammadi; Mona Kargar
Journal:  Ther Adv Drug Saf       Date:  2018-10-13

3.  Influence of Age on Warfarin Dose, Anticoagulation Control, and Risk of Hemorrhage.

Authors:  Aditi Shendre; Gaurav M Parmar; Chrisly Dillon; Timothy Mark Beasley; Nita A Limdi
Journal:  Pharmacotherapy       Date:  2018-02-27       Impact factor: 4.705

4.  Validation and Application of a Simple UHPLC-MS-MS Method for the Enantiospecific Determination of Warfarin in Human Urine.

Authors:  Osama Y Alshogran; Andrew J Ocque; François A Leblond; Vincent Pichette; Thomas D Nolin
Journal:  J Chromatogr Sci       Date:  2015-12-11       Impact factor: 1.618

5.  Pharmacoepidemiologic study of warfarin prescription in a Brazilian tertiary hospital.

Authors:  Camilo Molino Guidoni; Paulo Roque Obreli-Neto; Leonardo Regis Leira Pereira
Journal:  J Thromb Thrombolysis       Date:  2014-05       Impact factor: 2.300

6.  Drug-related problems and potential contributing factors in the management of deep vein thrombosis.

Authors:  Fekede Bekele Daba; Fisihatsion Tadesse; Ephrem Engidawork
Journal:  BMC Hematol       Date:  2016-02-04

7.  The Active Metabolite of Warfarin (3'-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study.

Authors:  Donato Gemmati; Francesco Burini; Anna Talarico; Matteo Fabbri; Cesare Bertocco; Marco Vigliano; Stefano Moratelli; Antonio Cuneo; Maria Luisa Serino; Francesco Maria Avato; Veronica Tisato; Rosa Maria Gaudio
Journal:  PLoS One       Date:  2016-09-08       Impact factor: 3.240

8.  Evaluation of CYP2C9- and VKORC1-based pharmacogenetic algorithm for warfarin dose in Gaza-Palestine.

Authors:  Basim Mohammad Ayesh; Ahmed Shaker Abu Shaaban; Abdalla Asaf Abed
Journal:  Future Sci OA       Date:  2018-01-10

9.  Effect of age and sex on warfarin dosing.

Authors:  Ghada Khoury; Marwan Sheikh-Taha
Journal:  Clin Pharmacol       Date:  2014-07-12

10.  Comparison of Warfarin Initiation at 3 mg Versus 5 mg for Anticoagulation of Patients with Mechanical Mitral Valve Replacement Surgery: A Prospective Randomized Trial.

Authors:  Sarah Sabry; Lamia Mohamed El Wakeel; Ayman Saleh; Marwa Adel Ahmed
Journal:  Clin Drug Investig       Date:  2022-03-10       Impact factor: 2.859

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.